First Eagle Investment Management
Holding/activity history for Quest Diagnostics (DGX)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
| 2024 Q3 | 4,949 | 0.00 | Add 11.24% | 0.00 | $155.38 |
| 2024 Q2 | 4,449 | 0.00 | Add 15.59% | 0.00 | $136.88 |
| 2024 Q1 | 3,849 | 0.00 | $133.02 | ||
| 2023 Q4 | 3,849 | 0.00 | $137.96 | ||
| 2023 Q3 | 3,849 | 0.00 | Add 4.85% | 0.00 | $121.85 |
| 2023 Q2 | 3,671 | 0.00 | $140.56 | ||
| 2023 Q1 | 3,671 | 0.00 | Add 1239.78% | 0.00 | $141.38 |
| 2022 Q4 | 274 | 0.00 | Reduce 8.36% | 0.00 | $156.93 |
| 2022 Q3 | 299 | 0.00 | Add 128.24% | 0.00 | $123.75 |
| 2022 Q2 | 131 | 0.00 | $129.77 | ||
| 2022 Q1 | 131 | 0.00 | Buy | 0.00 | $137.40 |